Physician profile
Frederick B Mcadam
NPI 1831148840
$5,483.71
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $739 · 2020: $484 · 2021: $2,486 · 2022: $1,262 · 2023: $446 · 2024: $67.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $513.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $513.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,026.06 | 2019-2023 | Octrode |
| Boston Scientific Corporation | $964.67 | 2019-2022 | |
| Nevro Corp. | $228.04 | 2020-2023 | Senza |
| Abbvie INC. | $186.40 | 2022-2023 | |
| Si-Bone, INC. | $185.94 | 2022 | |
| Relievant Medsystems, INC. | $174.36 | 2021 | |
| Merz Pharmaceuticals, LLC | $137.23 | 2021-2023 | Xeomin |
| Allergan, INC. | $106.13 | 2019-2020 | |
| Merz North America, INC. | $100.74 | 2019-2020 | |
| Medtronic, INC. | $77.20 | 2022-2024 | Intellis Adaptivestim |
| Spr Therapeutics, INC | $76.23 | 2023 | Sprint Pns System |
| Ipsen Biopharmaceuticals, INC | $54.81 | 2020-2021 | |
| Zyla Life Sciences, INC. | $41.00 | 2019-2020 | |
| Curonix LLC | $30.93 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Pacira Therapeutics, INC. | $25.72 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Assertio Therapeutics, INC. | $19.70 | 2020 | |
| Scilex Pharmaceuticals INC. | $17.35 | 2019 | |
| Pfizer INC. | $16.81 | 2019 | |
| Foundation Fusion Solutions, LLC | $14.39 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frederick Mcadam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.